Ivim Health vs MEDVi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Ivim Health beats MEDVi overall, scoring 7.9/10 vs 7.7/10. Ivim Health is more affordable at $150/mo vs $299/mo. Choose Ivim Health for users who want personalized dosing with frequent provider ch. Choose MEDVi for users who want a low entry price with oral and injectable co.
A side-by-side comparison of Ivim Health and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.
Ivim Health
#11 of 40Personalized GLP-1 program with frequent provider check-ins and customized dosing schedules at an affordable price point.
Visit Ivim HealthMEDVi
#21 of 40Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDVi| Feature | Ivim Health | MEDVi |
|---|---|---|
| Our Score | 7.9/10 | 7.7/10 |
| Starting Price | $150/mo | $299/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want personalized dosing with frequent provider check-ins | Users who want a low entry price with oral and injectable compounded options |
| Ranking | #11 | #21 |
Pros & Cons Compared
Ivim Health
Pros
- +$75/mo starting price is among the lowest in the market for a program with actual provider oversight
- +Bi-weekly provider check-ins included — more frequent than most platforms at this price point
- +Personalized titration schedules based on individual tolerance, not cookie-cutter dose escalation
- +Both brand-name and compounded available, with the option to switch based on response
Cons
- −The $75/mo starting price increases with dose — expect $150-200/mo at maintenance doses
- −No insurance billing, and the cost increase at higher doses isn't always clearly communicated upfront
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
Ivim Health edges out MEDVi with a score of 7.9/10 vs 7.7/10. If budget is your priority, Ivim Health starts at $150/mo compared to MEDVi's $299/mo. Ivim Health offers both brand-name and compounded medications, giving you more flexibility. Choose Ivim Health if you want: users who want personalized dosing with frequent provider check-ins. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.